Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: diabetes

High risk of death for individuals with C282Y/C282Y hereditary haemochromatosis and diabetes

Presented By
Dr Mathis Mottelson, Copenhagen University Hospital, Denmark
Conference
EHA 2023

2 August, 2023 17:05

Multifaceted strategy improves prescription of therapies for diabetes and ASCVD

Presented By
Prof. Neha Pagidipati, Duke University Hospital, NC, USA
Trial
COORDINATE-Diabetes
Conference
ACC 2023

7 June, 2023 09:55

Diabetes not related to abnormal biomarkers of Alzheimer’s disease

Presented By
Veerle van Gils, Maastricht University, the Netherlands
Conference
ECNP 2022

28 November, 2022 10:53

FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status

Presented By
Prof. Gerasimos Filippatos , Attikon University Hospital, Greece
Trial
Phase 3, FIDELIO-DKD, FIGARO-DKD
Conference
HFA 2022

28 July, 2022 12:09

Therapeutic approaches in heart failure with diabetes

Presented By
Prof. Lynne Stevenson, Vanderbilt University Medical Center, USA
Conference
AHA 2021

14 January, 2022 14:48

PFGC 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
PFGC 2021

22 December, 2021 08:12

Obesity: A risk factor for new-onset asthma and worse asthma control

Presented By
Prof. Fernando Holguin, University of Colorado Asthma Research and Education, CO, USA
Trial
Cohort study, CARDIA
Conference
ATS 2021

5 July, 2021 13:52

No increased risk of (severe) COVID-19 among IBD patients

Presented By
Dr Vered Richter , Tel Aviv University, Israel
Conference
ECCO 2021

2 July, 2021 23:52

Finerenone lowers CV events in diabetic CKD patients

Presented By
Prof. Gerasimos Filippatos, National and Kapodistrian University of Athens, Greece
Trial
Phase 3, FIDELIO-DKD
Conference
AHA 2020

18 February, 2021 11:33

Dapagliflozin reduces renal risk independent of CV disease status

Presented By
Prof. John McMurray, University of Glasgow, Scotland
Trial
DAPA-CKD
Conference
AHA 2020

18 February, 2021 10:18

“Strongly consider an SGLT2-inhibitor in most T2DM patients”

Presented By
Prof. Deepak Bhatt, Brigham and Women’s Hospital, USA
Trial
Phase 3, SOLOIST-WHF; SCORED
Conference
AHA 2020

18 February, 2021 10:14

2020 Sports Cardiology and Exercise in Cardiovascular Patients Guidelines

Presented By
Prof. Antonio Pelliccia, Institute of Sports Medicine and Science, Italy
Conference
ESC 2020

5 November, 2020 13:53

SGLT2 inhibitor improves cardiovascular outcomes in heart failure patients

Presented By
Dr Milton Packer, Baylor University Medical Center, USA
Trial
Phase 3, EMPEROR-Reduced trial
Conference
ESC 2020

5 November, 2020 13:40

DAPA-CKD: Dapagliflozin improves CKD survival ± diabetes

Presented By
Prof. Hiddo Heerspink, University of Groningen, the Netherlands
Trial
DAPA-CKD trial
Conference
ESC 2020

5 November, 2020 13:23

Antisense ANGPTL3 lowers triglycerides

Presented By
Prof. Daniel Gaudet, University of Montréal, Canada
Conference
ESC 2020

5 November, 2020 12:50

SGLT2 inhibitor ertugliflozin shows similar mortality but fewer HF hospitalisations

Presented By
Prof. Francesco Cosentino, Karolinska University Hospital, Sweden
Trial
VERTIS CV
Conference
ESC 2020

5 November, 2020 12:39

The Yale COVID-19 Cardiovascular Registry

Presented By
Dr Manan Pareek, Yale University School of Medicine, USA
Trial
Yale COVID-19 Cardiovascular Registry
Conference
ESC 2020

5 November, 2020 12:24

TWILIGHT sub-study: same outcomes for diabetes patients

Presented By
Prof. D. Angiolillo, University of Florida - Jacksonville, USA
Trial
TWILIGHT, TWILIGHT-DM
Conference
ACC 2020

8 September, 2020 15:24

DECLARE TIMI-58 trial shows benefits of dapagliflozin in high-risk subgroups

Conference
ACC 2019

4 June, 2019 14:16
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy